| 0.3548 Delayed Data As of Jun 19 |  +0.008 / +2.31%Today’s Change | 0.31 Today|||52-Week Range 1.84 | -18.87% Year-to-Date |
| BioLineRx to Present at the JMP Securities 2019 Life Sciences Conference Jun 13 / PR NewswirePRN - Paid Partner Content |
| Previous close | 0.35 |
| Today’s open | 0.34 |
| Day’s range | 0.34 - 0.37 |
| Volume | 682,279 |
| Average volume (3 months) | 996,412 |
| Market cap | $50.8M |
| Earnings growth (last year) | +22.47% |
| Earnings growth (this year) | +19.05% |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.96 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPNTOpiant Pharmaceutica... | -0.13 | -0.97% |
| ZFGNZafgen Inc | +0.01 | +0.71% |
| ISEEIVERIC bio Inc | -0.02 | -1.52% |
| --Innovative Pharmaceu... | -0.00 | -2.63% |
| Next reporting date | August 7, 2019 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer Philip Adam Serlin |
Chief Financial Officer Mali Zeevi |
Corporate headquarters Modi'in, Tel Aviv |
